Excision Bio
Philadelphia, United States · Founded 2015 · $60.0M raised
- Headquarters
- Philadelphia, Pennsylvania
- Founded
- 2015
- Business Model
- B2B
- Website
- excisionbio.com
- Total Funding
- $60.0M
- Last Round
- $60.0M Series BOct 2021
- Rounds
- 1
About
Excision BioTherapeutics develops CRISPR-based gene editing therapeutics targeting viral infections including HIV.
Summary
Excision Bio is a Biotech company based in Philadelphia, United States, founded in 2015. It has raised $60.0M in total across 1 round, most recently a $60.0M Series B round in Oct 2021.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2021
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...